Clinical Trials Logo

Wounds, Nonpenetrating clinical trials

View clinical trials related to Wounds, Nonpenetrating.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02961699 Active, not recruiting - Clinical trials for Wound, Nonpenetrating

Healing Chronic Venous Stasis Wounds With Autologous Cell Therapy

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

This is a prospective, randomized, single-site, safety and efficacy study of subjects with chronic venous stasis ulcers. Patients will fall into two categories: treatment arm (24 subjects) and non-treatment or control arm (12 subjects). The treatment group will undergo a small liposuction procedure and receive placement of autologous cell therapy (stromal vascular fraction or SVF) injected around the rim of venous stasis wound (subcutaneously)following standard wound debridement, with saturation of collagen dressing material with standard over-dressing. Control (non-treatment) subjects will receive debridement and dressing changes as per standard of care without SVF.

NCT ID: NCT01367951 Active, not recruiting - Rib Fracture Clinical Trials

Treatment of Acute, Unstable Chest Wall Injuries

Start date: July 2011
Phase: N/A
Study type: Interventional

Unstable chest injuries are common in poly trauma patients. They can lead to severe pulmonary restriction, loss of lung volume, difficulty with ventilation and can render the patient to require intubation and mechanical ventilation. Traditionally these injuries have been treated non-operatively, however in the past decade there has been numerous studies suggesting improved outcomes with surgical fixation. Surgical fixation can significantly decrease time spent in ICU as well as day on mechanical ventilation. The investigators aim is to conduct a randomized control trial of these injuries, to compare non-operative treatment with surgical fixation. The investigators' hypothesis is that surgically treated patient will have significantly improved outcomes compared to those treated non-operatively.